Effect of Paliperidone Palmitate 3-Month Formulation on Goal Attainment and Disability After 52 Weeks’ Treatment in Patients with Clinically Stable Schizophrenia

PURPOSE: This pragmatic clinical study aimed to assess goal attainment among patients with schizophrenia treated with paliperidone palmitate 3-monthly (PP3M) and its relation to their level of disability, and whether patients achieved symptomatic remission at the study endpoint. PATIENTS AND METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Lambert, Martin, Sanchez, Pedro, Bergmans, Paul, Gopal, Srihari, Mathews, Maju, Wooller, Annette, Pungor, Katalin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767727/
https://www.ncbi.nlm.nih.gov/pubmed/33380797
http://dx.doi.org/10.2147/NDT.S286654

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767727/
https://www.ncbi.nlm.nih.gov/pubmed/33380797
http://dx.doi.org/10.2147/NDT.S286654

Ejemplares similares